KINIKSA PHARMACEUTICALS INTE(NASDAQ:KNSA) stock News

KNSA Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Chartmill

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Exhibits High Growth Momentum and Technical Breakout Potential

8 days ago - By: Chartmill

KINIKSA PHARMACEUTICALS INTE (NASDAQ:KNSA): A Strong Growth Stock with a Positive Technical Breakout

10 hours ago - By: Zacks Investment Research - Mentions: CRMD OTLK PHAR

OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug

a day ago - By: Kiniksa Pharmaceuticals International, Plc

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

a day ago - By: Zacks Investment Research - Mentions: INO CRMD PGEN

INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug

3 days ago - By: Zacks Investment Research - Mentions: CPRX CRMD PHAR

Catalyst Pharmaceuticals Settles Firdapse Patent Litigation With Lupin

11 days ago - By: Zacks Investment Research

Wall Street Analysts Believe Kiniksa Pharmaceuticals International, plc (KNSA) Could Rally 26.69%: Here's is How to Trade

11 days ago - By: Zacks Investment Research

Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why

15 days ago - By: Zacks Investment Research - Mentions: TPC ESEA MOD LIF

Zacks.com featured highlights include Modine Manufacturing, Tutor Perini, Kiniksa Pharmaceuticals International and Euroseas

16 days ago - By: Zacks Investment Research - Mentions: GSK TBPH CRMD

Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y

17 days ago - By: Zacks Investment Research - Mentions: TPC ESEA MOD LIF

5 Stocks With Recent Price Strength Amid Trade & Rate Cut Uncertainties

24 days ago - By: Zacks Investment Research

Kiniksa Pharmaceuticals International, plc (KNSA) Is Up 21.46% in One Week: What You Should Know

26 days ago - By: Investor's Business Daily - Mentions: GILD AUPH INCY

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?

a month ago - By: Zacks Investment Research

Why Kiniksa Pharmaceuticals International, plc (KNSA) Might be Well Poised for a Surge

a month ago - By: Zacks Investment Research

Does Kiniksa Pharmaceuticals International, plc (KNSA) Have the Potential to Rally 35.96% as Wall Street Analysts Expect?

a month ago - By: Zacks Investment Research

Here's Why Momentum in Kiniksa Pharmaceuticals International, plc (KNSA) Should Keep going

a month ago - By: Kiniksa Pharmaceuticals International, Plc

Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution

a month ago - By: Benzinga

Earnings Preview: Kiniksa Pharmaceuticals

a month ago - By: Kiniksa Pharmaceuticals International, Plc

Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025

2 months ago - By: The Motley Fool

Kiniksa Pharmaceuticals: A 7.9 Score and Room for Growth

3 months ago - By: Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis

3 months ago - By: Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

4 months ago - By: Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

4 months ago - By: Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

4 months ago - By: Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution

4 months ago - By: Benzinga

Examining the Future: Kiniksa Pharmaceuticals's Earnings Outlook

4 months ago - By: Kiniksa Pharmaceuticals, Ltd.

KINIKSA PHARMACEUTICALS INTE (KNSA) Stock News

KNSA Latest News, Press Relases and Analysis

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Exhibits High Growth Momentum and Technical Breakout Potential

KINIKSA PHARMACEUTICALS INTE (NASDAQ:KNSA): A Strong Growth Stock with a Positive Technical Breakout

OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug

Catalyst Pharmaceuticals Settles Firdapse Patent Litigation With Lupin

Wall Street Analysts Believe Kiniksa Pharmaceuticals International, plc (KNSA) Could Rally 26.69%: Here's is How to Trade

Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks.com featured highlights include Modine Manufacturing, Tutor Perini, Kiniksa Pharmaceuticals International and Euroseas

Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y

5 Stocks With Recent Price Strength Amid Trade & Rate Cut Uncertainties

Kiniksa Pharmaceuticals International, plc (KNSA) Is Up 21.46% in One Week: What You Should Know

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?

Why Kiniksa Pharmaceuticals International, plc (KNSA) Might be Well Poised for a Surge

Does Kiniksa Pharmaceuticals International, plc (KNSA) Have the Potential to Rally 35.96% as Wall Street Analysts Expect?

Here's Why Momentum in Kiniksa Pharmaceuticals International, plc (KNSA) Should Keep going

Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution

Earnings Preview: Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025

Kiniksa Pharmaceuticals: A 7.9 Score and Room for Growth

Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution

Examining the Future: Kiniksa Pharmaceuticals's Earnings Outlook

Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025